[1] Characteristics of Streptococcus pseudopneumoniae isolated from purulent sputum samples

[2] The NOW S. pneumoniae urinary antigen test positivity rate 6 weeks after pneumonia onset and among patients with COPD

[3] Relationships between respiratory and airway resistances and activity-related dyspnea in patients with chronic obstructive pulmonary disease

[4] Self-management plans in the primary care of patients with chronic obstructive pulmonary disease

[5] Thirteen kinds of Chinese medicine injections for acute exacerbation of chronic obstructive pulmonary disease: Protocol for a systematic review and network meta-analysis.

[6] Overview of pneumococcal serotypes and genotypes causing diseases in patients with chronic obstructive pulmonary disease in a Spanish hospital between 2013 and 2016

[7] Current perspectives on treatment of hypertensive patients with chronic obstructive pulmonary disease

[8] Overview of pneumococcal serotypes and genotypes causing diseases in patients with chronic obstructive pulmonary disease in a Spanish hospital between 2013 and 2016

[9] Current perspectives on treatment of hypertensive patients with chronic obstructive pulmonary disease

[10] Impact of chronic obstructive pulmonary disease on mortality: A large national cohort study.

[11] Recommendations and practices for holistic chronic obstructive pulmonary disease (COPD) assessment and optimal referral patterns in emergency department presentations: a scoping review protocol.

[12] Sleep disturbance in patients with mild-moderate chronic obstructive pulmonary disease.

[13] Internet Health Behaviors of Patients with Chronic Obstructive Pulmonary Disease and Assessment of Two Disease Websites.

[14] Role of Electrocardiographic Manifestations in Admission Decision in Patients with Chronic Obstructive Pulmonary Disease Exacerbation.

[15] Progression of erectile function in men with chronic obstructive pulmonary disease: a cohort study.

[16] Characterization of non-tuberculous mycobacterial pulmonary disease in Nanjing district of China.

[17] T-regulatory cells subpopulation in bronchial asthma and heterogeneous phenotypes of chronic obstructive pulmonary disease

[18] Chinese Herbal Medicine Versus Placebo for the Treatment Of Chronic Obstructive Pulmonary Disease: A Protocol of Systematic Review and Meta-analysis.

[19] Safety and efficacy of acupuncture for the treatment of chronic obstructive pulmonary disease: A systematic review protocol.

[20] PHYSIOTHERAPEUTIC APPROACHES AND THE EFFECTS ON INSPIRATORY MUSCLE FORCE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE PRE-OPERATIVE PREPARATION FOR ABDOMINAL SURGICAL PROCEDURES.

[21] Pharmacological interventions for the treatment of anxiety and panic in chronic obstructive pulmonary disease

[22] Changes in lower limb muscle function and muscle mass following exercise-based interventions in patients with chronic obstructive pulmonary disease: A review of the English-language literature

[23] Association between Chronic Obstructive Pulmonary Disease and Dementia: Systematic Review and Meta-Analysis of Cohort Studies.

[24] Air pollution exposures from multiple point sources and risk of incident chronic obstructive pulmonary disease (COPD) and asthma.

[25] Pulmonary rehabilitation for people with chronic obstructive pulmonary disease: A protocol for an overview of Cochrane reviews.

[26] Effect of marijuana smoking on pulmonary disease in HIV-infected and uninfected men: a longitudinal cohort study.

[27] Prevalence of chronic obstructive pulmonary disease (COPD) and its associated factors among adults in Abeshge District, Ethiopia: a cross sectional study.

[28] Real-world effectiveness of umeclidinium/vilanterol versus fluticasone propionate/salmeterol as initial maintenance therapy for chronic obstructive pulmonary disease (COPD): a retrospective cohort study.

[29] Computer-Mediated Experiences of Patients with Chronic Obstructive Pulmonary Disease.

[30] The Social and Economic Impact of Chronic Obstructive Pulmonary Disease on Maintenance-of-Way Railroad Workers.

[31] Large-scale external validation and comparison of prognostic models: an application to chronic obstructive pulmonary disease

[32] Unique synergistic antiviral effects of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive pulmonary disease.

[33] Diabetes Mellitus and Chronic Obstructive Pulmonary Disease: An Overview.

[34] Pathogenesis of chronic obstructive pulmonary disease (COPD) induced by cigarette smoke.

[35] Chronic obstructive pulmonary disease and metabolic syndrome: Traveling with bad companies

[36] Is oxidative stress associated with disease severity, pulmonary function and metabolic syndrome in chronic obstructive pulmonary disease?

[37] TCM nonpharmacological interventions for chronic obstructive pulmonary disease (COPD): Protocol for a systematic review and network meta-analysis.

[38] Obstructive pulmonary disease in patients with previous tuberculosis: Pathophysiology of a community-based cohort

[39] Comorbidity: pulmonary tuberculosis and chronic obstructive pulmonary disease

[40] Antimicrobial prescription in patients dying from chronic obstructive pulmonary disease.

[41] Long-term air humidification therapy is cost-effective for patients with moderate or severe chronic obstructive pulmonary disease or bronchiectasis.

[42] Acute care costs of patients admitted for management of chronic obstructive pulmonary disease exacerbations: contribution of disease severity, infection and chronic heart failure.

[43] Serum Heat Shock Protein Levels and the Relationship of Heat Shock Proteins with Various Parameters in Chronic Obstructive Pulmonary Disease Patients.

[44] Short Physical Performance Battery: What Does Each Sub-Test Measure in Patients with Chronic Obstructive Pulmonary Disease?

[45] Intermittent Treatment with Azithromycin and Ethambutol for Noncavitary Mycobacterium avium Complex Pulmonary Disease

[46] Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease

[47] Response to letter to the Editor re ‘Pulmonary Rehabilitation Adapted Index of Self-Efficacy (PRAISE) tool predicts reduction in sedentary time following pulmonary rehabilitation in people with Chronic Obstructive Pulmonary Disease (COPD)’

[48] Adherence to Therapy in Chronic Obstructive Pulmonary Disease: A Systematic Review.

[49] Performance of the Binax NOW Streptococcus pneumoniae urinary antigen assay for diagnosis of pneumonia in children with underlying pulmonary diseases in the absence of acute pneumococcal infection

[50] Role of Type2 Inflammatory Biomarkers in Chronic Obstructive Pulmonary Disease

[51] Performance of the Binax NOW Streptococcus pneumoniae Urinary Antigen Assay for Diagnosis of Pneumonia in Children with Underlying Pulmonary Diseases in the Absence of Acute Pneumococcal Infection

[52] β-blockers after acute myocardial infarction in patients with chronic obstructive pulmonary disease: a nationwide population-based observational study.

[53] satisfaction and experience with a supervised home-based real-time videoconferencing telerehabilitation exercise program in people with chronic obstructive pulmonary disease (copd)

[54] inhaled corticosteroids should not be prescribed to all chronic obstructive pulmonary disease patients

[55] chronic obstructive pulmonary disease, diagnosis and treatment

[56] health status measurement instruments in chronic obstructive pulmonary disease

[57] the validity of diagnosing chronic obstructive pulmonary disease from a large administrative database

[58] os fenótipos da doença pulmonar obstrutiva crónica e a sua relevância clínica chronic obstructive pulmonary disease phenotypes and their clinical relevance

[59] myeloperoxidase promoter polymorphism −463g is associated with more severe clinical expression of cystic fibrosis pulmonary disease

[60] cardiovascular and respiratory dysfunction in chronic obstructive pulmonary disease complicated by impaired peripheral oxygenation

[61] procalcitonin: is it a predictor of noninvasive positive pressure ventilation necessity in acute chronic obstructive pulmonary disease exacerbation?

[62] association of alpha-1 antitrypsin level and lung function in patients with chronic obstructive pulmonary disease

[63] biomarkers in exhaled breath condensate and serum of chronic obstructive pulmonary disease and non-small-cell lung cancer

[64] anemias in chronic obstructive pulmonary disease

[65] paradoxical association between body mass index and in-hospital mortality in elderly patients with chronic obstructive pulmonary disease in japan

[66] the association of chronic obstructive pulmonary disease, disability, engagement in social activities, and mortality among us adults aged 70 years or older, 1994–2006

[67] study the association of chronic obstructive pulmonary disease with early endothelial dysfunction and its impact on cardiovascular system by estimating urinary albumin creatinine ratio

[68] estudo de quatro anos de tiotrópio na doença pulmonar obstrutiva crónica (estudo uplift) a 4-year trial of tiotropium in chronic obstructive pulmonary disease (uplift trial)

[69] compliance of patients with chronic obstructive pulmonary disease to a pulmonary rehabilitation program

[70] the chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in copd

[71] magnesium for acute exacerbation of chronic obstructive pulmonary disease: a systematic review of randomised trials

[72] prevalence of chronic obstructive pulmonary disease among adult male cigarettes smokers: a community-based study in jordan

[73] chronic obstructive pulmonary disease and sexual functioning among women in egypt

[74] frequency and clinical relevance of human bocavirus infection in acute exacerbations of chronic obstructive pulmonary disease

[75] improvement of airflow limitation by fluticasone propionate/salmeterol in chronic obstructive pulmonary disease: what is the specific marker?

[76] The immediate effect of soft tissue manual therapy intervention on lung function in severe chronic obstructive pulmonary disease

[77] roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease

[78] an overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease

[79] balance impairment and systemic inflammation in chronic obstructive pulmonary disease

[80] risks of on-pump coronary artery bypass grafting surgery in patients with chronic obstructive pulmonary disease due to sulfur mustard

[81] the burden of illness related to chronic obstructive pulmonary disease exacerbations in québec, canada

[82] endothelial dysfunction and morphofunctional properties of erythrocytes in non-alcoholic steathohepatitis combined with chronic obstructive pulmonary disease in patients with obesity

[83] systemic inflammation in chronic pulmonary diseases – are we here now?

[84] doença pulmonar obstrutiva crônica e fatores associados em são paulo, sp, 2008-2009 enfermedad pulmonar obstructiva crónica y factores asociados en sao paulo, sureste de brasil, 2008-2009 prevalence of chronic obstructive pulmonary disease and risk factors in são paulo, brazil, 2008-2009

[85] treinamento de força para pacientes com doença pulmonar obstrutiva crônica strength training for patients with chronic obstructive pulmonary disease

[86] chronic obstructive pulmonary disease and cardiac comorbidities: a cross-sectional study

[87] why understanding the asthma chronic obstructive pulmonary disease overlap syndrome (acos) is important to the clinician

[88] characteristics of stable chronic obstructive pulmonary disease patients in the pulmonology clinics of seven asian cities

[89] guideline-based early detection of chronic obstructive pulmonary disease in eight danish municipalities: the top-kom study

[90] efficacy and safety of eco-friendly inhalers: focus on combination ipratropium bromide and albuterol in chronic obstructive pulmonary disease

[91] fine particulate air pollution and hospital admissions for chronic obstructive pulmonary disease: a case-crossover study in taipei

[92] cognitive functions in nonhypoxemic chronic obstructive pulmonary disease (copd)

[93] self-reported alcohol intake and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study

[94] discharge medication counseling and its correlation with reducing readmissions for patients with chronic obstructive pulmonary disease exacerbations

[95] improving the quality of life in patients with chronic obstructive pulmonary disease: focus on indacaterol

[96] proinflammatory cytokine expression in patients with chronic obstructive pulmonary disease

[97] association of egr-1 and autophagy-related gene polymorphism in men with chronic obstructive pulmonary disease

[98] pulmonary rehabilitation in patients with chronic obstructive pulmonary disease

[99] effect of a pulmonary rehabilitation program on the levels of anxiety and depression and on the quality of life of patients with chronic obstructive pulmonary disease

[100] disease perception of moroccan immigrants with chronic obstructive pulmonary disease: a qualitative study

[101] asthma-chronic obstructive pulmonary disease overlap (aco): an emerging entity in allergic respiratory diseases